Meet a leader making waves in women’s health technology. This innovative executive combines scientific expertise with entrepreneurial vision.
The journey began with a strong academic foundation in nutrition and molecular medicine. This background provides the scientific basis for developing health-focused technology solutions.
Recognition came recently through the 2024 Enterprise Ireland High-Potential Start-Up Founder of the Year Award. This honor was selected by peer founders from 67 participating startups.
Before the current venture, there was proven success in product development. Previous experience includes co-founding a menu analysis company and leading projects at a firm specializing in muscle health.
The mission now focuses on revolutionizing perimenopause management through AI-powered wearable technology. The company previously operated under a different name before rebranding.
Key Takeaways
- Strong background in nutrition and molecular medicine provides scientific foundation
- Recipient of prestigious 2024 Enterprise Ireland Founder of the Year Award
- Proven track record in bringing health products from concept to market
- Focus on developing AI-driven solutions for women’s health challenges
- Experience spans multiple health technology ventures and companies
- Commitment to addressing gaps in perimenopause management technology
- Leadership recognized by peer entrepreneurs in the startup community
Founding Journey and Company Background
In 2022, a new venture emerged to address critical gaps in women’s healthcare technology. The business began when two innovators with complementary expertise joined forces.
The Inception of Peri and IdentifyHer
The company originally launched as IdentifyHer, reflecting its mission to help women understand their health patterns. This initial brand identity captured the founders’ commitment to supporting long-term women’s wellness.
They quickly identified a significant void in perimenopause symptom data. This discovery shaped the entire direction of their entrepreneurial journey.
Key Milestones Since 2022
The business received crucial support from Enterprise Ireland throughout its development phase. This backing helped navigate the complex startup landscape.
Significant recognition came when the company was honored as a CES Innovation Awards Honoree in Digital Health. This milestone marked a turning point for the technology.
| Year | Milestone | Significance |
|---|---|---|
| 2022 | Company Founding | Established with focus on women’s health data gap |
| 2023-2024 | Enterprise Ireland Support | Secured funding and business infrastructure |
| 2025 | CES Innovation Award | International recognition in digital health |
| November 2025 | U.S. Pre-orders Open | Market expansion preparation |
The founder’s dedication to transforming healthcare through data-driven solutions remains the driving force. This commitment continues to guide the company’s growth trajectory.
Leadership Vision and Industry Impact
Receiving peer recognition from fellow entrepreneurs often signifies true impact in the startup world. This was evident when the Enterprise Ireland Founder of the Year Award was presented in 2024.
Award Recognition and Entrepreneurial Commitment
The Enterprise Ireland High-Potential Start-Up Founder of the Year Awards reached their sixth year in 2024. This program acknowledges the commitment of entrepreneurs building world-class companies.
Nine high-potential startups were shortlisted for the prestigious award. The selection came from 67 participating startups in the Founders Forum.
The competition featured impressive innovators across various sectors. Here are the runners-up who showcased Ireland’s diverse entrepreneurial talent:
| Entrepreneur | Company | Innovation Focus |
|---|---|---|
| Barry McCann | Nua Surgical | Surgical retractors for C-sections |
| Mark Kirwan | Positive Carbon | AI-powered food waste calculator |
| Dr. Alison Liddy | Relevium Medical | Solutions for chronic pain |
Empowering Women Through Technological Innovation
The leadership vision extends beyond business success to empowering women through technology. Women’s health issues have long been overlooked in both medical and investment circles.
This commitment to addressing gaps in women’s health reflects a broader mission. The goal is to provide solutions for millions experiencing perimenopause symptoms.
Navigating Investor Challenges in Women’s Health
Securing funding presented significant hurdles. Perimenopause symptoms vary dramatically between individuals and change over time.
This variability made explaining the market opportunity challenging to potential investors. The product’s classification as non-medical created additional barriers in traditional funding channels.
Despite these obstacles, the determination to bring innovative solutions forward remained strong. The entrepreneurial spirit prevailed in pushing through systemic challenges.
Heidi Davis – CEO & Co-founder – Peri: Driving Innovation in Women’s Health
A revolutionary wearable technology is transforming how women understand their perimenopause journey. This innovation addresses a critical gap in women’s health technology by providing objective data where subjective reporting previously dominated.
AI-Powered Wearable Device and Personalized Insights
The wearable device represents a breakthrough in symptom management. Worn discreetly under the breast, it uses proprietary biosensing technology to passively track physiological signals.
This technology identifies key symptoms including anxiety, hot flashes, and sleep disruption. The device profiles these symptoms across menstrual cycles and tracks changes over time.
The AI-driven analytics provide insights guide women toward personalized management plans. Users receive actionable data to make informed decisions about lifestyle adjustments or clinical support.
Bridging the Gender Health Data Gap
Research reveals staggering gaps in perimenopause care. Seventy percent of women seeking help receive no treatment due to poor diagnostics.
Eighty-four percent report not being believed by healthcare providers. This technology validates women’s experiences with concrete data.
The device empowers users to control their health information. Women choose who to share data with while accessing insights that guide women toward better outcomes.
Available for $449 with FSA/HSA eligibility, this technology makes symptom management accessible. Pre-orders are open for December 2025 delivery.
Conclusion
Bringing innovative technology to the global market represents the culmination of an ambitious journey. The recognition through the Enterprise Ireland Founder of the Year Awards during their sixth year celebration underscores this achievement.
Peer acknowledgment from the Founders Forum community highlights the collaborative spirit driving this success. The ongoing partnership with Enterprise Ireland continues to support the business as it prepares for market entry.
The vision extends far beyond initial launch plans. This leader aims to reach women across the world, transforming how they manage health challenges.
Empowering women with control over their wellbeing stands as the core mission. The technology provides insights that help improve physical, mental, and emotional health.
Closing the gender health data gap represents a fundamental shift in women health approaches. Millions will gain confidence navigating life stages with better information.
The future looks bright for this growing venture. Its impact on lives worldwide will continue expanding through dedicated innovation and compassionate leadership.